Join Agendia for a Multidisciplinary Discussion on the Increasing Role of Genomic Profiling in Early Stage Breast Cancer
- Understand the latest data supporting the utility of Agendia’s assays: MammaPrint® andBluePrint® for early-stage breast cancer patients
- Review and appreciate the real-world impact of MammaPrint and BluePrint
- Recommend genomic profiling for pre-and post-operative breast cancer treatment planning
This virtual webinar presentation featuring Dr. Cathy Graham & Dr. William Audeh was broadcast on 21st June 2022.
